Royal Bank Of Canada Global Blood Therapeutics, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $7.03 Million - $14.8 Million	-216,982 Reduced 51.83%	201,624 $13.7 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $1.48 Million - $2.49 Million	66,520 Added 18.89%	418,606 $13.4 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $7.05 Million - $9.77 Million	274,497 Added 353.78%	352,086 $12.2 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $562,640 - $909,714	22,596 Added 41.09%	77,589 $2.27 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $486,056 - $712,297	19,076 Added 53.11%	54,993 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $1.17 Million - $1.56 Million	35,917 New	35,917 $1.26 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.